LCN2 and neoplasm: Tumour markers such as CA19-9, IL-6, and neutrophil gelatinase-associated lipocalin (NGAL), although are typically raised in CCA, do not have sufficient discriminatory power to be clinically useful in Klatskin mimicking lesions [8–11].